The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Shopping
    • Stores
    • Coupons
    • Daily Double
    • Promotion
    • How It Works
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • National

    PRUDEN: Obama's due process doctrine

  • National

    U.S. links 8 to Somali terrorist group

  • Business

    Home sales surge 10.1 percent in October

  • Local

    Fenty trails Gray in D.C. poll

  • Politics

    S.C. governor faces 37 ethics violations

  • National

    China holds lawyer who tried to see Obama

  • World

    Israel-Hamas prisoner swap talks advance

Thursday, November 18, 2004

Vioxx creates trouble for FDA

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos

More Stories

  • D.C. sports icon, Wizards owner Pollin dead at 85
  • Medical pot gets social
  • Soccer fans' ire stoked
  • Obama has plan to 'finish job' in Afghanistan

By

ASSOCIATED PRESS

The public is "virtually defenseless" if another medication such as Vioxx proves unsafe after it has won Food and Drug Administration approval, a government drug-safety expert said yesterday.

"I would argue that the FDA as currently configured is incapable of protecting America against another Vioxx," said Dr. David Graham, who warned that the arthritis-relief drug had been linked to an increased risk of heart attack and stroke.

He told the Senate Finance Committee of at least five other drugs on the market that warrant scrutiny: the acne-reducing drug Accutane, the weight-loss drug Meridia, the cholesterol-lowering drug Crestor, pain-reliever Bextra and the asthma-relief drug Serevent.

Astra-Zeneca Pharmaceuticals, maker of Crestor, said it was confident that the drug was safe.

"To date, the FDA has not given us any indication of a major concern regarding Crestor," spokeswoman Emily Denney said.

Tim Lindberg, a spokesman for Abbott Laboratories, said, "Science continues to support the safe use of Meridia to treat obesity, the leading health epidemic in the U.S."

Carolyn Glynn, spokeswoman for Roche Holdings AG, a manufacturer of Accutane, noted the drug is intended for serious cases and does carry risks.

"This drug is extremely beneficial as long as it's used safely and appropriately," she said.

GlaxoSmithKline, which makes Serevent, said the medication is safe and effective "when used appropriately and in accordance with labeling and treatment guidelines."

12Next »

Post a comment

There are comments on this article, submit your opinion!

Commenting is disabled for this entry.
If you feel there is still something worth mentioning about this entry please contact the author or the site admin.

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. EDITORIAL: Hiding evidence of global cooling
  2. Top Republican lawmakers not attending State Dinner
  3. Islamic center in Maryland keeps ties to Iran
  4. EDITORIAL EXCLUSIVE: On terrorists, Justice recused
  5. Religious leaders vow civil disobedience on anti-life issues
More Top Stories »
  1. KELLNER: New Apple mouse really is 'Magic'
  2. Fenty trails Gray in D.C. poll
  3. Massive bill steals show in health care debate
  4. Conservatives seek test for RNC funds
  5. Food snobs fork over $225 for taste of heritage turkey

Most Shared

  1. EDITORIAL: Hiding evidence of global cooling
  2. The United Socialist States of America
  3. PRUDEN: Obama's due process doctrine
  4. Top Republican lawmakers not attending State Dinner
  5. Fenty trails Gray in D.C. poll
More Top Stories »
  1. Conservatives seek test for RNC funds
  2. Food snobs fork over $225 for taste of heritage turkey
  3. EDITORIAL: Terrorists use Democratic talking points
  4. LETTER TO EDITOR: When family ties die
  5. Religious leaders vow civil disobedience on anti-life issues

Most Commented

  1. EDITORIAL: Hiding evidence of global cooling
  2. Top Republican lawmakers not attending State Dinner
  3. Conservatives seek test for RNC funds
  4. Lobbyists spending big to shape health care debate
  5. PRUDEN: Obama's due process doctrine
More Top Stories »
  1. Schumer: Dems will pass health bill alone
  2. Green energy stimulus growing few jobs
  3. EDITORIAL: Schumer's change of heart
  4. EDITORIAL: Terrorists use Democratic talking points
  5. WH: Obama Afghan decision 'within days'

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Blogs & Columns

  • Hot Button Blog

    RNC: Breast cancer recommendations may lead to 'rationing'

  • Belief Blog

    Evangelicals OK civil disobedience

  • Out of Context

    Foods that might kill libido

  • On the Fly

    United lifts some 'award' blocking

  • Technology

    Facebook wins round against phishing spammer

  • Redskins 360

    Gray spends day in Memphis

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.